We are live on ! Find out more
KBIO

KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE)
KBIO

Delisted

KBIO was delisted on the 16th of December, 2015.

Back to rankings

1 hedge funds and large institutions have $65K invested in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) in 2016 Q1 according to their latest regulatory filings, with 0 funds opening new positions, increasing their positions, 0 reducing their positions, and 16 closing their positions.

New
Increased
Maintained
Reduced
Closed

94% less funds holding

Funds holding: 17 → 1 (-16)

99% less capital invested

Capital invested by funds: $4.45M → $65K (-$4.38M)

100% less first-time investments, than exits

New positions opened: 0 | Existing positions closed: 16

Holders
1
Holders Change
-16
Holders Change %
-94.12%
% of All Funds
0.03%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
–
Increased
–
Reduced
–
Closed
16
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

No buyers this quarter

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$2.61M
2
BIT
BlackRock Institutional Trust
California
-$620K
3
Morgan Stanley
Morgan Stanley
New York
-$472K
4
Balyasny Asset Management
Balyasny Asset Management
Illinois
-$223K
5
Geode Capital Management
Geode Capital Management
Massachusetts
-$150K
Name Holding Trade Value Shares
Change 		Change in
Stake
California Public Employees Retirement System
1
California Public Employees Retirement System
California
$65K – – –
Renaissance Technologies
2
Renaissance Technologies
New York
– -$2.61M -110,522 Closed
Morgan Stanley
3
Morgan Stanley
New York
– -$472K -47,139 Closed
BIT
4
BlackRock Institutional Trust
California
– -$620K -40,000 Closed
Geode Capital Management
5
Geode Capital Management
Massachusetts
– -$150K -13,679 Closed
Balyasny Asset Management
6
Balyasny Asset Management
Illinois
– -$223K -9,440 Closed
Deutsche Bank
7
Deutsche Bank
Germany
– -$84K -5,468 Closed
UBS Group
8
UBS Group
Switzerland
– -$27K -1,736 Closed
TRCT
9
Tower Research Capital (TRC)
New York
– -$3K -300 Closed
Creative Planning
10
Creative Planning
Kansas
– -$2K -100 Closed
Federated Hermes
11
Federated Hermes
Pennsylvania
– -$1K -38 Closed
AIG
12
American International Group
New York
– -$1K -35 Closed

KBIO Hedge Fund Activity: Q1 2016 in Review

1 of the 3,753 institutional investors tracked by Wall St. Rank reported a position in KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) for Q1 2016, worth a combined $65K — down 99% from $4.45M a quarter earlier.

Sellers outnumbered buyers: 16 funds closed out of KBIO and 0 opened new positions — a net loss of 16 holders — while 0 trimmed existing stakes and 0 added.

The largest seller was Renaissance Technologies, exiting entirely with an estimated $2.61M sold.

  • 1 institutional investor held KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) (KBIO) as of Q1 2016, down from 17 in Q4 2015.
  • Funds reported $65K of KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) stock for Q1 2016, down 99% quarter-over-quarter.
  • 0 funds opened new KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) positions in Q1 2016 and 16 closed out, a net change of -16 holders.
  • The largest KALOBIOS PHARMACEUTICALS INC COM STK NEW (DE) seller in Q1 2016 was Renaissance Technologies, an estimated $2.61M sold.

Based on aggregated 13F filings for Q1 2016.